Cardiorespiratory findings in sudden unexplained/unexpected death in epilepsy (SUDEP)

Epilepsy Research

Volumn 59, Issue 1, 2004, Pages 51-60

  Stöllberger, Claudia ^a   Finsterer, Josef ^b  

^a Second Medical Department   (Austria)

^b KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

Author keywords

Arrhythmia; Epilepsy; Sudden death; SUDEP

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; DIETHYLCARBAMAZINE; ETHOSUXIMIDE; FELBAMATE; FOSPHENYTOIN SODIUM; GABAPENTIN; LAMOTRIGINE; LIFARIZINE; LORAZEPAM; OXCARBAZEPINE; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

APNEA; ARRHYTHMOGENESIS; ATRIOVENTRICULAR CONDUCTION; AUTONOMIC NERVOUS SYSTEM; AUTOPSY; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYMPTOM; CASE FINDING; CHOLINERGIC TRANSMISSION; DEFIBRILLATOR; DIABETES MELLITUS; DISEASE SEVERITY; DRUG USE; ELECTROCARDIOGRAPHY; ELECTROLYTE DISTURBANCE; EPILEPSY; EPILEPTIC DISCHARGE; FAMILY HISTORY; HEART; HEART ARRHYTHMIA; HEART DILATATION; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; LUNG DISEASE; LUNG FUNCTION; MEDICAL RECORD; NEUROLOGIC DISEASE; NONHUMAN; POPULATION RISK; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEIZURE; SIDE EFFECT; SMOKING; SUDDEN DEATH; SYMPATHETIC TONE;

EID: 2342600567     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2004.03.008     Document Type: Article

References (76)

1. Abe Y., Kondo M., Matsuoka R., Araki M., Dohyama K., Tanito H. Assessment of clinical features in transient left ventricular apical ballooning. J. Am. Coll. Cardiol. 41:2003;737-742
2. Annegers J.F., Coan P.S. SUDEP: overview of definitions and review of incidence data. Seizure. 8:1999;347-352
3. Behr, E. Wood, D.A., Wright, M., Syrris, P., Sheppard, M.N., Casey, A., Davies, M.J., McKenna, W, Sudden Arrhythmic Death Syndrome (SADS) Steering Group, 2003. Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet 362, 1457-1459.
4. Betts T., Goodwin G., Withers R.M., Yuen A.W. Human safety of lamotrigine. Epilepsia. 32(Suppl. 2):1991;S17-S21
5. Browne T.R., Mattson R.H., Penry J.K., Smith D.B., Treiman D.M., Wilder B.J., Ben-Menachem E., McBride R.G., Sherry K.M. Multicenter long-term safety and efficacy study of vigabatrin for refractory complex partial seizures: an update. Neurology. 41:1991;363-364
6. Cohle S.D., Suarez-Mier M.P., Aguilera B. Sudden death resulting from lesions of the cardiac conduction system. Am. J. Forensic Med. Pathol. 23:2002;83-89
7. Corrado D., Basso C., Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc. Res. 50:2001;399-408
8. Dasheiff R.M. Sudden unexpected death in epilepsy: a series from an epilepsy surgery program and speculation on the relationship to sudden cardiac death. J. Clin. Neurophysiol. 8:1991;216-222
9. Davies M.J. The investigation of sudden cardiac death. Histopathology. 34:1999;93-98
10. Deibert E., Barzilai B., Aiyagari V., Dacey R., Diringer M. Clinical significance of elevated troponin I levels in patients with nontraumatic subarachnoid hemorrhage. J. Neurosurg. 98:2003;741-746
11. Devinsky O., Pacia S., Tatambhotla G. Bradycardia and asystole induced by partial seizures: a case report and literature review. Neurology. 6:1997;1712-1714
12. Drake M.E., Reider C.R., Kay A. Electrocardiography in epilepsy patients without cardiac symptoms. Seizure. 2:1993;63-65
13. Falconer B., Rajs J. Post-mortem findings of cardiac lesions in eplileptics: a preliminary report. Forensic Sci. 8:1976;63-71
14. Ficker D.M., So E.L., Shen W.K., Annegers J.F., O'BrienC Cascino P.G.D., Belau P.G. Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology. 51:1998;1270-1274
15. Gerber N., Mays D.C., Donn K.H., Laddu A., Guthrie R.M., Turlapaty P., Quon C.Y., Rivenburg W.K. Safety, tolerance and pharmacokinetics of intravenous doses of the phosphate ester of 3-hydroxymethyl-5, 5-diphenylhydantoin: a new prodrug of phenytoin. J. Clin. Pharmacol. 28:1988;1023-1032
16. Gogtay N.J., Dalvi S.S., Mhatre R.B., Kirodian B.G., Gupta A.H., Jadhav S.P., Kshirsagar N.A. A randomized, crossover, assesor-blind study of the bioequivalence of a single oral dose of 200 mg of four formulations of phenytoin sodium in healthy, normal Indian volunteers. Ther. Drug Monit. 25:2003;215-220
17. Hennessy M.J., Tighe M.G., Binnie C.D., Nashef L. Sudden withdrawal of carbamazepine increases cardiac sympathetic activity in sleep. Neurology. 57:2001;1650-1654
18. Hilz M.J., Devinsky O., Doyle W., Mauerer A., Dütsch M. Decrease of sympathetic cardiovascular modulation after temporal lobe epilepsy surgery. Brain. 125:2002;985-995
19. Isojärvi J.I., Ansakorpi H., Suominen K., Repo M., Myllyla V.V. Interictal cardiovascular autonomic responses in patients with epilepsy. Epilepsia. 39:1998;420-426
20. Iwahashi, K., 1996. Significantly higher plasma haloperidol level during cotreatment with carbamazepine may herald cardiac change. 19, 267-270.
21. Johnston S.C., Horn J.K., Valente J., Simon R.P. The role of hypoventilation in a sheep model of epileptic sudden death. Ann. Neurol. 37:1995;531-537
22. Kalviainen R., Brodie M.J., Duncan J., Chadwick D., Edwards D., Lyby K. A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group. Epilepsy Res. 30:1998;31-40
23. Kasarskis E.J., Kuo C.S., Berger R., Nelson K.R. Carbamazepine-induced cardiac dysfunction. Characterization of two distinct clinical syndromes. Arch. Intern. Med. 152:1992;186-191
24. Keegan M.T., Bondy L.R., Blackshear J.L., Lanier W.L. Hypocalcemia-like electrocardiographic changes after administration of intravenous fosphenytoin. Mayo Clin. Proc. 77:2002;584-586
25. Keilson M.J., Hauser A., Magrill J.P., Goldman M. ECG abnormalities in patients with epilepsy. Neurology. 37:1987;1624-1626
26. Kenneback G., Bergfeldt L., Vallin H., Tomson T., Edhag O. Electrophysiologic effects and clinical hazards of carbamazepine treatment for neurologic disorders in patients with abnormalities of the cardiac conduction system. Am. Heart J. 121:1991;1421-1429
27. Kenneback G., Bergfeldt L., Tomson T. Electrophysiological evaluation of the sodium-channel blocker carbamazepine in healthy human subjects. Cardiovasc. Drugs Ther. 9:1995;709-714
28. Kloster R., Borresen H.C., Hoff-Olsen P. Sudden death in two patients with epilepsy and the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Seizure. 7:1998;419-420
29. Kloster R., Engelskjon T. Sudden unexpected death in epilepsy (SUDEP): a clinical perspective and a search for risk factors. J. Neurol. Neurosurg. Psychiatry. 67:1999;439-444
30. Langan Y., Nashef L., Sander J.W.A.S. Sudden unexpected death in epilepsy: a series of witnessed deaths. J. Neurol. Neurosurg. Psychiatry. 68:2000;211-213
31. Langan Y., Nashef L., Sander J.W.A.S. Certification of deaths attributable to epilepsy. J. Neurol. Neurosurg. Psychiatry. 73:2002;751-752
32. Lathers C.M., Schraeder P.L. Clinical pharmacology: drugs as a benefit and/or risk in sudden unexpected death in epilepsy? J. Clin. Pharmacol. 42:2002;123-136
33. Lathers C.M., Schraeder P.L., Weiner F.L. Synchronization of cardiac autonomic neural discharge with epileptogenic activity: the lockstep phenomenon. Electroencephalogr. Clin. Neurophysiol. 67:1987;247-259
34. Leestma J.E., Annegers J.F., Brodie M.J., Brown S., Schraeder P., Siscovick D., Wannamaker B.B., Tennis P.S., Cierpial M.A., Earl N.L. Sudden unexplained death in epilepsy: observations from a large clinical development program. Epilepsia. 38:1997;47-55
35. Leestma J.E., Walczak T., Hughes J.R., Kalelkar M.B., Teas S.S. A prospective study on sudden unexpected death in epilepsy. Ann. Neurol. 26:1989;195-203
36. Linzer M., Grubb B.P., Ho S., Ramakrishnan L., Bromfield E., Estes N.A.M. Cardiovascular causes of loss of consciousness in patients with presumed epilepsy: a cause of the increased sudden death rate in people with epilepsy? Am. J. Med. 96:1994;146-154
37. Loukeris K., Mauri D., Pazarlis P. QT length and heart function in primidone hypocalcemia. Acta Cardiol. 57:2002;367-369
38. Meehan K.M., Wang H., David S.R., Nisivoccia J.R., Jones B., Beasley C.M. Jr., Feldman P.D., Mintzer J.E., Beckett L.M., Breier A. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology. 26:2002;494-504
39. Nashef L., Brown S. Epilepsy and sudden death. Lancet. 348:1996;1324-1325
40. Nashef L., Fish D.R., Sander J.W., Shorvon S.D. Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referal centre. J. Neurol. Neurosurg. Psychiatry. 58:1995;462-464
41. Nashef L., Garner S., Sander J.W.A.S., Fish D.R., Shorvon S.D. Circumstances of death in sudden death in epilepsy: interviews of bereaved relatives. J. Neurol. Neurosurg. Psychiatry. 64:1998;349-352
42. Nashef L., Walker F., Allen P., Sander J.W.A.S., Shorvon S.D., Fish D.R. Apnoea and bradycardia during epileptic seizures: relation to sudden death in epilepsy. J. Neurol. Neurosurg. Psychiatry. 60:1996;297-300
43. Natelson B.H., Suarez R.V., Terrence C.F., Turizo R. Patients with epilepsy who die suddenly have cardiac disease. Arch. Neurol. 55:1998;857-860
44. Nei M., Ho R.T., Sperling M.R. EKG abnormalities during partial seizures in refractory epilepsy. Epilepsia. 41:2000;542-548
45. Nilsson L., Diwan V., Farahmand B.Y., Persson P.G., Tomson T. Antiepileptic drug therapy and its management in sudden unexpected death in epilepsy: a case-control study. Epilepsia. 42:2001;667-673
46. Nilsson L., Farahmand B.Y., Persson P.G., Thiblin I., Tomson T. Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet. 353:1999;888-893
47. Opeskin K., Thomas A., Berkovic S.F. Does cardiac conduction pathology contribute to sudden unexpected death in epilepsy? Epilepsy Res. 40:2000;17-24
48. Opherk C., Coromilas J., Hirsch L.J. Heart rate and EKG changes in 102 seizures: analysis of influencing factors. Epilepsy Res. 52:2002;117-127
49. Ptacek L.J. Channelopathies: ion channel disorders of muscle as a paradigm for paroxysmal disorders of the nervous system. Neuromuscul. Disord. 7:1997;250-255
50. Racoosin J.A., Feeney J., Burkhart G., Boehm G. Mortality in antiepileptic drug development programs. Neurology. 56:2001;514-519
51. Randazzo D.N., Ciccone A., Schweitzer P., Winters S.L. Complete atrioventricular block with ventricular asystole following infusion of intravenous phenytoin. J. Electrocardiol. 28:1995;157-159
52. Reay D.T., Howard J.D., Fligner C.L., Ward R.J. Effects of positional restraint on oxygen saturation and heart rate following exercise. Am. J. Forensic Med. Pathol. 9:1998;16-18
53. Rocamora R., Kurthen M., Lickfett L., von Oertzen J., Elger C.E. Cardiac asystole in epilepsy: clinical and neurophysiologic features. Epilepsia. 44:2003;179-185
54. Röggla G., Röggla M. Death in a hobble restraint. CMAJ. 161:1999;21
55. Saarnivaara L., Hiller A., Oikkonen M. QT interval, heart rate and arterial pressures using propofol, thiopentone or methohexitone for induction of anaesthesia in children. Acta Anaesthesiol. Scand. 37:1993;419-423
56. Salmo E.N., Connolly C.E. Mortality in epilepsy in the West of Ireland: a 10-years review. Ir. J. Med. Sci. 171:2002;199-201
57. Shields L.B.E., Hunsaker D.M., Hunsaker J.C. Sudden unexpected death in epilepsy. Neuropathologic findings. Am. J. Forensic Med. Pathol. 23:2002;307-314
58. Sivakumaran S., Krahn A.D., Klein G.J., Finan J., Yee R., Renner S., Skanes A.C. A prospective randomized comparison of loop recorders versus Holter monitors in patients with syncope or presyncope. Am. J. Med. 115:2003;1-5
59. So E.L., Sam M.C., Lagerlund T.L. Postictal central apnea as a cause of SUDEP: evidence from near-SUDEP incident. Epilepsia. 41:2000;1494-1497
60. Sperling M.R., Feldman H., Kinman J., Liporace J.D., O'Connor M.J. Seizure control and mortality in epilepsy. Ann. Neurol. 46:1999;45-50
61. Tartara A., Manni R., Galimberti C.A., Hardenberg J., Orwin J., Perucca E. Vigabatrin in the treatment of epilepsy: a double-blind placebo-controlled study. Epilepsia. 27:1986;717-723
62. Tavernor S.J., Brown S.W., Tavernor R.M.E., Gifford C. Electrocardiograph QT lengthening associated with epileptiform EEG discharges - a role in sudden unexplained death in epilepsy? Seizure. 5:1996;79-83
63. Tennis P., Cole T.B., Annegers J.F., Leestma J.E., McNutt M., Rajput A. Cohort study of incidence of sudden unexplained death in persons with seizure disorder treated with antiepileptic drugs in Saskatchewan, Canada. Epilepsia. 36:1995;29-36
64. Thom M., Seetah S., Sisodiya S., Koepp M., Scaravilli F. Sudden and unexpected death in epilepsy (SUDEP): evidence of acute neuronal injury using HSP-70 and c-Jun immunohistochemistry. Neuropathol. Appl. Neurobiol. 29:2003;132-143
65. Tigaran S., Molgaard H., McClelland R., Dam M., Jaffe A.S. Evidence of cardiac ischemia during seizures in drug refractory epilepsy patients. Neurology. 60:2003;492-495
66. Timmings P.L. Sudden unexpected death in epilepsy: is carbamazepine implicated? Seizure. 7:1998;289-291
67. Tsuchihashi, K., Ueshima, K., Uchida, T., Oh-mura, N., Kimura, K., Owa, M., Yoshiyama, M., Miyazaki, S., Haze, K., Ogawa, H., Honda, T., Hase, M., Kai, R., Morii, I., Angina Pectoris-Myocardial Infarction Investigations in Japan, 2001. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. J. Am. Coll. Cardiol. 38, 11-18.
68. Tzivoni D., Butnaru A. Diagnostic accuracy of ST changes detected by exercise testing and ambulatory electrocardiographic monitoring in apparently healthy individuals. Am. Heart J. 137:1999;996-999
69. Venkataraman V., Wheless J.W. Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res. 35:1999;147-153
70. Venkataraman V., Wheless J.W., Willmore L.J., Motookal H. Idiopathic cardiac asystole presenting as an intractable adult onset partial seizure disorder. Seizure. 10:2001;359-364
71. Vogel L.R., Muskin P.R., Collins E.D., Sloan R.P. Lorazepam reduces cardiac vagal modulation in normal subjects. J. Clin. Psychopharmacol. 16:1996;449-453
72. Walczak T. Do antiepileptic drugs play a role in sudden unexpected death in eplilepsy? Drug Safety. 26:2003;673-683
73. Walczak T.S., Leppik I.E., D'Amelio M., Rarick J., So E., Ahman P., Ruggles K., Cascino G.D., Annegers J.F., Hauser W.A. Incidence and risk factors in sudden unexpected death in epilepsy. A prospective cohort study. Neurology. 56:2001;519-525
74. Woodruff B.K., BrittonW Tigaran J.S., Cascino G.D., Burritt M.F., McConnell J.P., Ravkilde J., Molgaard H., Andreasen F., Dam M., Jaffe A.S. Cardiac troponin levels following monitored epileptic seizures. Neurology. 60:2003;1690-1692
75. Zaidi A., Cotter L., Fitzpatrick A. Sudden unexplained death (letter). Lancet. 349:1997;135
76. Zijlmans M., Flanagan D., Gotman J. Heart rate changes and ECG abnormalities during epileptic seizures: prevalence and definition of an objective clinical sign. Epilepsia. 43:2002;847-854